Aristeia Capital’s Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HZON.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-86,860
Closed -$82K 857
2021
Q4
$82K Hold
86,860
﹤0.01% 585
2021
Q3
$79K Hold
86,860
﹤0.01% 516
2021
Q2
$102K Buy
+86,860
New +$136K ﹤0.01% 474

Other funds holding HZON.WS

Aristeia Capital's HZON.WS Position: Q1 2022 in Review

Aristeia Capital sold out of Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HZON.WS) in Q1 2022, closing a stake of 86,860 shares — an estimated $82K sold.

Aristeia Capital first reported a position in HZON.WS in Q2 2021 and held it in 3 quarters. The position peaked at $102K in Q2 2021. 35 funds tracked by Wall St. Rank hold HZON.WS as of Q1 2022.

  • Aristeia Capital reported no remaining Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Aristeia Capital sold 86,860 Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $82K.
  • Aristeia Capital first reported a position in Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 3 quarters.
  • Aristeia Capital's Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $102K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Aristeia Capital's 13F filing for Q1 2022, filed 16 May 2022.